- Home
- BSTZ vs IMCR Comparison
BSTZ vs IMCR Comparison
Compare BSTZ & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSTZ
- IMCR
- Stock Information
- Founded
- BSTZ 2019
- IMCR 2008
- Country
- BSTZ United States
- IMCR United Kingdom
- Employees
- BSTZ N/A
- IMCR N/A
- Industry
- BSTZ Trusts Except Educational Religious and Charitable
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BSTZ Finance
- IMCR Health Care
- Exchange
- BSTZ Nasdaq
- IMCR Nasdaq
- Market Cap
- BSTZ 1.4B
- IMCR 1.7B
- IPO Year
- BSTZ N/A
- IMCR 2021
- Fundamental
- Price
- BSTZ $21.22
- IMCR $39.08
- Analyst Decision
- BSTZ
- IMCR Buy
- Analyst Count
- BSTZ 0
- IMCR 9
- Target Price
- BSTZ N/A
- IMCR $67.00
- AVG Volume (30 Days)
- BSTZ 303.2K
- IMCR 274.6K
- Earning Date
- BSTZ 01-01-0001
- IMCR 11-06-2025
- Dividend Yield
- BSTZ 8.31%
- IMCR N/A
- EPS Growth
- BSTZ N/A
- IMCR N/A
- EPS
- BSTZ 0.71
- IMCR N/A
- Revenue
- BSTZ N/A
- IMCR $379,590,000.00
- Revenue This Year
- BSTZ N/A
- IMCR $30.11
- Revenue Next Year
- BSTZ N/A
- IMCR $8.89
- P/E Ratio
- BSTZ $26.69
- IMCR N/A
- Revenue Growth
- BSTZ N/A
- IMCR 28.11
- 52 Week Low
- BSTZ $14.11
- IMCR $23.15
- 52 Week High
- BSTZ $19.43
- IMCR $40.07
- Technical
- Relative Strength Index (RSI)
- BSTZ 37.74
- IMCR 72.16
- Support Level
- BSTZ $20.85
- IMCR $34.30
- Resistance Level
- BSTZ $21.99
- IMCR $40.07
- Average True Range (ATR)
- BSTZ 0.53
- IMCR 1.52
- MACD
- BSTZ -0.17
- IMCR 0.64
- Stochastic Oscillator
- BSTZ 17.97
- IMCR 89.60
About BSTZ BlackRock Science and Technology Term Trust of Beneficial Interest
BlackRock Science and Technology Trust II is a non-diversified, closed-end management investment company. The trust's investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. Its portfolio consists of Equity Securities, Options, Preferred Securities, Convertible Securities, Depositary Receipts, Non-U.S. Securities, Emerging Markets Investments, Restricted and Illiquid Investments, Private Company Investments, Corporate Bonds, and other investments. The trust seeks to Invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. science and technology companies in any market capitalization range from the development, advancement, and use of science and/or technology.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.